ID BLAS1_SERMA Reviewed; 294 AA. AC P52682; Q54488; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 05-FEB-2025, sequence version 2. DT 04-NOV-2026, entry version 92. DE RecName: Full=Beta-lactamase SME-1 {ECO:0000303|PubMed:21840669, ECO:0000303|PubMed:7793864, ECO:0000303|PubMed:8092824}; DE EC=3.5.2.6 {ECO:0000269|PubMed:11036019, ECO:0000269|PubMed:8092824}; DE Flags: Precursor; GN Name=SME-1 {ECO:0000303|PubMed:21840669, ECO:0000303|PubMed:7793864, GN ECO:0000303|PubMed:8092824}; GN Synonyms=blaSME-1 {ECO:0000312|EMBL:AGZ03855.1}, blaSME-4 GN {ECO:0000312|EMBL:AHA49908.1}, blaSME1 {ECO:0000312|EMBL:AEJ79644.1}, GN bpl-1, bplA, sme-2 {ECO:0000312|EMBL:AAB03414.1}, smeA; OS Serratia marcescens. OC Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; OC Enterobacterales; Yersiniaceae; Serratia. OX NCBI_TaxID=615; RN [1] {ECO:0000312|EMBL:AAB03414.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 28-38, FUNCTION, RP CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES, AND RP INDUCTION. RC STRAIN=S6 {ECO:0000312|EMBL:AAB03414.1}; RX PubMed=8092824; DOI=10.1128/aac.38.6.1262; RA Naas T., Vandel L., Sougakoff W., Livermore D.M., Nordmann P.; RT "Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing RT class A beta-lactamase, Sme-1, from Serratia marcescens S6."; RL Antimicrob. Agents Chemother. 38:1262-1270(1994). RN [2] {ECO:0000305} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-32, AND INDUCTION BY BETA-LACTAMS. RC STRAIN=S6; RX PubMed=7793864; DOI=10.1128/aac.39.3.629; RA Naas T., Livermore D.M., Nordmann P.; RT "Characterization of an LysR family protein, SmeR from Serratia marcescens RT S6, its effect on expression of the carbapenem-hydrolyzing beta-lactamase RT Sme-1, and comparison of this regulator with other beta-lactamase RT regulators."; RL Antimicrob. Agents Chemother. 39:629-637(1995). RN [3] {ECO:0000312|EMBL:AAB03414.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=S6 {ECO:0000312|EMBL:AAB03414.1}; RA Rasmussen B.A., Keeney D., Cohen C.; RT "Carbapenem-hydrolyzing beta-lactamase, Sme-2."; RL Submitted (JUN-1996) to the EMBL/GenBank/DDBJ databases. RN [4] {ECO:0000312|EMBL:AEJ79644.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=SMDET-2 {ECO:0000312|EMBL:AEJ79644.1}; RX PubMed=21840669; DOI=10.1016/j.diagmicrobio.2011.06.007; RA Fairfax M.R., Queenan A.M., Lephart P.R., Kaye K.S., Dror M., Arnous N., RA Salimnia T.T., Mitchell R.A., Alangaden G., Salimnia H.; RT "Detection of 2 SME-1 carbapenemase-producing Serratia marcescens in RT Detroit."; RL Diagn. Microbiol. Infect. Dis. 71:325-326(2011). RN [5] {ECO:0000312|EMBL:AHA49908.1} RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RC STRAIN=41727R {ECO:0000312|EMBL:AHA49908.1}; RA Farrell S.E., Castanheira M., Jones R.N.; RT "Characterization of carbapenem resistant isolates from 2012."; RL Submitted (JUL-2013) to the EMBL/GenBank/DDBJ databases. RN [6] {ECO:0000312|EMBL:AGZ03855.1} RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=N12-0620 {ECO:0000312|EMBL:AGZ03855.1}; RX PubMed=24659751; DOI=10.1093/jac/dku040; RA Mataseje L.F., Boyd D.A., Delport J., Hoang L., Imperial M., Lefebvre B., RA Kuhn M., Van Caeseele P., Willey B.M., Mulvey M.R.; RT "Serratia marcescens harbouring SME-type class A carbapenemases in Canada RT and the presence of blaSME on a novel genomic island, SmarGI1-1."; RL J. Antimicrob. Chemother. 69:1825-1829(2014). RN [7] {ECO:0000305} RP AMINO ACID NUMBERING SCHEME. RX PubMed=2039479; DOI=10.1042/bj2760269; RA Ambler R.P., Coulson A.F., Frere J.M., Ghuysen J.M., Joris B., Forsman M., RA Levesque R.C., Tiraby G., Waley S.G.; RT "A standard numbering scheme for the class A beta-lactamases."; RL Biochem. J. 276:269-270(1991). RN [8] RP FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL RP PROPERTIES, AND MUTAGENESIS OF VAL-207. RX PubMed=11036019; DOI=10.1128/aac.44.11.3035-3039.2000; RA Queenan A.M., Torres-Viera C., Gold H.S., Carmeli Y., Eliopoulos G.M., RA Moellering R.C. Jr., Quinn J.P., Hindler J., Medeiros A.A., Bush K.; RT "SME-type carbapenem-hydrolyzing class A beta-lactamases from RT geographically diverse Serratia marcescens strains."; RL Antimicrob. Agents Chemother. 44:3035-3039(2000). RN [9] {ECO:0007744|PDB:1DY6} RP X-RAY CRYSTALLOGRAPHY, FUNCTION, DISULFIDE BOND, AND MUTAGENESIS OF CYS-72. RX PubMed=11807251; DOI=10.1107/s0907444901019606; RA Sougakoff W., L'Hermite G., Pernot L., Naas T., Guillet V., Nordmann P., RA Jarlier V., Delettre J.; RT "Structure of the imipenem-hydrolyzing class A beta-lactamase SME-1 from RT Serratia marcescens."; RL Acta Crystallogr. D 58:267-274(2002). CC -!- FUNCTION: Class A beta-lactamase which confers resistance to the beta- CC lactam antibiotics, including penicillins, some cephalosporins and CC carbapenems, to JM109 strain E.coli (PubMed:11807251, PubMed:8092824). CC Acts via hydrolysis of the beta-lactam ring (PubMed:11036019, CC PubMed:8092824). Has penicillin-, cephalosporin- and carbapenem- CC hydrolyzing activities (PubMed:11036019). {ECO:0000269|PubMed:11036019, CC ECO:0000269|PubMed:11807251, ECO:0000269|PubMed:8092824}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-lactam + H2O = a substituted beta-amino acid; CC Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627, CC ChEBI:CHEBI:140347; EC=3.5.2.6; CC Evidence={ECO:0000269|PubMed:11036019, ECO:0000269|PubMed:8092824}; CC -!- ACTIVITY REGULATION: Partially inhibited by the beta-lactamase-blocking CC agents, clavulanic acid and tazobactam (PubMed:11036019, CC PubMed:8092824). Not inhibited by EDTA (PubMed:11036019, CC PubMed:8092824). {ECO:0000269|PubMed:11036019, CC ECO:0000269|PubMed:8092824}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=16.7 uM for penicillin (at pH 7.0 and 25 degrees Celsius) CC {ECO:0000269|PubMed:11036019}; CC KM=488 uM for ampicillin (at pH 7.0 and 25 degrees Celsius) CC {ECO:0000269|PubMed:11036019}; CC KM=770 uM for cephaloridine (at pH 7.0 and 25 degrees Celsius) CC {ECO:0000269|PubMed:11036019}; CC KM=202 uM for imipenem (at pH 7.0 and 25 degrees Celsius) CC {ECO:0000269|PubMed:11036019}; CC KM=13.4 uM for meropenem (at pH 7.0 and 25 degrees Celsius) CC {ECO:0000269|PubMed:11036019}; CC KM=259 uM for aztreonam (at pH 7.0 and 25 degrees Celsius) CC {ECO:0000269|PubMed:11036019}; CC KM=62 uM for aztreonam (at pH 7.0) {ECO:0000269|PubMed:8092824}; CC Note=kcat is 19.3 sec(-1) with penicillin as substrate (at pH 7.0 and CC 25 degrees Celsius) (PubMed:11036019). kcat is 181 sec(-1) with CC ampicillin as substrate (at pH 7.0 and 25 degrees Celsius) CC (PubMed:11036019). kcat is 980 sec(-1) with cephaloridine as CC substrate (at pH 7.0 and 25 degrees Celsius) (PubMed:11036019). kcat CC is 104 sec(-1) with imipenem as substrate (at pH 7.0 and 25 degrees CC Celsius) (PubMed:11036019). kcat is 8.9 sec(-1) with meropenem as CC substrate (at pH 7.0 and 25 degrees Celsius) (PubMed:11036019). kcat CC is 108 sec(-1) with aztreonam as substrate (at pH 7.0 and 25 degrees CC Celsius) (PubMed:11036019). {ECO:0000269|PubMed:11036019}; CC -!- INDUCTION: Up-regulated by the carbapenem, imipenem (PubMed:7793864). CC Expression probably regulated by upstream promoter elements CC (PubMed:8092824). {ECO:0000269|PubMed:7793864, CC ECO:0000269|PubMed:8092824}. CC -!- MISCELLANEOUS: The class A beta-lactamase family has a specific amino- CC acid numbering system, sometimes called Ambler or ABL numbering and CC often misspelt as Amber. A multiple sequence alignment was used to CC derive a consensus sequence and then the consensus was numbered taking CC into account insertions and deletions. This allows use of identical CC numbers, e.g. for active site residues, despite differences in protein CC length. UniProt always uses natural numbering of residues, hence there CC appear to be differences in numbering between this entry and some CC papers. {ECO:0000305|PubMed:2039479}. CC -!- SIMILARITY: Belongs to the class-A beta-lactamase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U60295; AAB03414.1; -; Genomic_DNA. DR EMBL; JF974075; AEJ79644.1; -; Genomic_DNA. DR EMBL; KF615855; AGZ03855.1; -; Genomic_DNA. DR EMBL; KF481967; AHA49908.1; -; Genomic_DNA. DR EMBL; Z28968; CAA82281.1; -; Genomic_DNA. DR EMBL; Z30237; CAA82944.1; -; Genomic_DNA. DR PIR; S44080; S44080. DR RefSeq; WP_063864730.1; NG_050137.1. DR PDB; 1DY6; X-ray; 2.13 A; A/B=28-294. DR PDB; 9IL7; X-ray; 2.40 A; A/B=28-294. DR PDB; 9IL8; X-ray; 2.30 A; A/B=28-294. DR PDB; 9IL9; X-ray; 2.28 A; A/B=28-294. DR PDB; 9ILE; X-ray; 2.38 A; A=28-294. DR PDB; 9IO6; X-ray; 2.07 A; A/B=28-294. DR PDB; 9IO7; X-ray; 2.40 A; A=28-294. DR PDB; 9IOW; X-ray; 2.40 A; A=28-294. DR PDB; 9IVL; X-ray; 1.40 A; A=28-294. DR PDB; 9JNA; X-ray; 2.40 A; A/B=28-294. DR PDB; 9JNB; X-ray; 2.20 A; A=28-294. DR PDB; 9JNC; X-ray; 2.57 A; A/B=28-294. DR PDB; 9JND; X-ray; 2.30 A; A/B=28-294. DR PDB; 9JNE; X-ray; 2.50 A; A/B=28-294. DR PDB; 9JNF; X-ray; 2.32 A; A/B=28-294. DR PDB; 9JNG; X-ray; 2.26 A; A/B=28-294. DR PDB; 9UJ5; X-ray; 2.30 A; A/B=28-294. DR PDB; 9UJ6; X-ray; 2.00 A; A/B=28-294. DR PDB; 9UJ7; X-ray; 2.20 A; A/B=28-294. DR PDB; 9UJ8; X-ray; 2.10 A; A=28-294. DR PDB; 9UJ9; X-ray; 2.40 A; A/B=28-294. DR PDB; 9UJA; X-ray; 2.20 A; A=28-294. DR PDB; 9UJB; X-ray; 2.10 A; A/B=28-294. DR PDB; 9UJC; X-ray; 2.00 A; A=28-294. DR PDB; 9V49; X-ray; 2.20 A; A/B=28-294. DR PDB; 9V4A; X-ray; 2.40 A; A=28-294. DR PDB; 9VIU; X-ray; 2.80 A; A/B=28-294. DR PDB; 9VXS; X-ray; 2.50 A; A/B=28-294. DR PDB; 9W7N; X-ray; 2.00 A; A/B=28-294. DR PDB; 9W7O; X-ray; 1.93 A; A/B=28-294. DR PDB; 9W7P; X-ray; 2.20 A; A/B=28-294. DR AlphaFoldDB; P52682; -. DR SMR; P52682; -. DR CARD; ARO:3002382; SME-4; ARO:0001004; antibiotic inactivation. DR MEROPS; S11.A01; -. DR KEGG; ag:CAA82281; -. DR PATRIC; fig|615.109.peg.3851; -. DR SABIO-RK; P52682; -. DR EvolutionaryTrace; Q54488; -. DR GO; GO:0008800; F:beta-lactamase activity; EXP:UniProtKB. DR GO; GO:0030655; P:beta-lactam antibiotic catabolic process; IEA:InterPro. DR GO; GO:0046677; P:response to antibiotic; IEA:InterPro. DR Gene3D; 3.40.710.10; DD-peptidase/beta-lactamase superfamily; 1. DR InterPro; IPR012338; Beta-lactam/transpept-like. DR InterPro; IPR045155; Beta-lactam_cat. DR InterPro; IPR000871; Beta-lactam_class-A. DR InterPro; IPR058220; KPC-2/SME-1-like. DR InterPro; IPR058198; SME-1. DR NCBIfam; NF033103; bla_class_A; 1. DR NCBIfam; NF012142; blaSME; 1. DR NCBIfam; NF000538; classA_carba; 1. DR PANTHER; PTHR35333; BETA-LACTAMASE; 1. DR PANTHER; PTHR35333:SF3; BETA-LACTAMASE-TYPE TRANSPEPTIDASE FOLD CONTAINING PROTEIN; 1. DR Pfam; PF13354; Beta-lactamase2; 1. DR PRINTS; PR00118; BLACTAMASEA. DR SUPFAM; SSF56601; beta-lactamase/transpeptidase-like; 1. PE 1: Evidence at protein level; KW 3D-structure; Antibiotic resistance; Direct protein sequencing; KW Disulfide bond; Hydrolase; Signal. FT SIGNAL 1..27 FT /evidence="ECO:0000269|PubMed:8092824" FT CHAIN 28..294 FT /note="Beta-lactamase SME-1" FT /id="PRO_0000017001" FT ACT_SITE 73 FT /note="Nucleophile; acyl-ester intermediate" FT /evidence="ECO:0000250|UniProtKB:P62593" FT ACT_SITE 76 FT /note="Proton acceptor" FT /evidence="ECO:0000250|UniProtKB:P62593" FT ACT_SITE 133 FT /note="Proton donor" FT /evidence="ECO:0000250|UniProtKB:P62593" FT ACT_SITE 170 FT /note="Proton acceptor" FT /evidence="ECO:0000250|UniProtKB:P62593" FT BINDING 73 FT /ligand="a beta-lactam" FT /ligand_id="ChEBI:CHEBI:35627" FT /evidence="ECO:0000250|UniProtKB:Q9F663" FT BINDING 76 FT /ligand="a beta-lactam" FT /ligand_id="ChEBI:CHEBI:35627" FT /evidence="ECO:0000250|UniProtKB:Q9F663" FT BINDING 133 FT /ligand="a beta-lactam" FT /ligand_id="ChEBI:CHEBI:35627" FT /evidence="ECO:0000250|UniProtKB:Q9F663" FT BINDING 135 FT /ligand="a beta-lactam" FT /ligand_id="ChEBI:CHEBI:35627" FT /evidence="ECO:0000250|UniProtKB:Q9F663" FT BINDING 239 FT /ligand="a beta-lactam" FT /ligand_id="ChEBI:CHEBI:35627" FT /evidence="ECO:0000250|UniProtKB:Q9F663" FT DISULFID 72..242 FT /evidence="ECO:0000269|PubMed:11807251, FT ECO:0007744|PDB:1DY6" FT MUTAGEN 72 FT /note="C->A: Abolishes resistance to imipenem, amoxicillin, FT ticarcillin, cefoxitin and aztreonam in the JM109 strain FT E.coli." FT /evidence="ECO:0000269|PubMed:11807251" FT MUTAGEN 207 FT /note="V->E: Similar catalytic efficiency to wild-type with FT respect to penicillins, cephalosporins and carbapenems." FT /evidence="ECO:0000269|PubMed:11036019" FT CONFLICT 245 FT /note="Y -> I (in Ref. 1; FT AAB03414/AEJ79644/AGZ03855/AHA49908)" FT /evidence="ECO:0000305" FT HELIX 33..44 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 46..54 FT /evidence="ECO:0007829|PDB:9IVL" FT TURN 55..58 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 59..64 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 72..75 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 76..88 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 103..106 FT /evidence="ECO:0007829|PDB:9IL7" FT HELIX 110..114 FT /evidence="ECO:0007829|PDB:9IVL" FT TURN 115..118 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 122..131 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 135..141 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 142..146 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 148..158 FT /evidence="ECO:0007829|PDB:9IVL" FT TURN 170..175 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 182..185 FT /evidence="ECO:0007829|PDB:9V49" FT HELIX 187..198 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 200..203 FT /evidence="ECO:0007829|PDB:9W7O" FT HELIX 207..216 FT /evidence="ECO:0007829|PDB:9IVL" FT TURN 222..224 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 225..228 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 233..241 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 248..255 FT /evidence="ECO:0007829|PDB:9IVL" FT STRAND 257..259 FT /evidence="ECO:0007829|PDB:9UJC" FT STRAND 262..269 FT /evidence="ECO:0007829|PDB:9IVL" FT HELIX 279..293 FT /evidence="ECO:0007829|PDB:9IVL" SQ SEQUENCE 294 AA; 32247 MW; C326C0DC65293094 CRC64; MSNKVNFKTA SFLFSVCLAL SAFNAHANKS DAAAKQIKKL EEDFDGRIGV FAIDTGSGNT FGYRSDERFP LCSSFKGFLA AAVLERVQQK KLDINQKVKY ESRDLEYHSP ITTKYKGSGM TLGDMASAAL QYSDNGATNI IMERFLGGPE GMTKFMRSIG DNEFRLDRWE LELNTAIPGD KRDTSTPKAV ANSLNKLALG NVLNAKVKAI YQNWLKGNTT GDARIRASVP ADWVVGDKTG SCGAYGTAND YAVIWPKNRA PLIVSIYTTR KSKDDKHSDK TIAEASRIAI QAID //